Effect of travoprost on intraocular pressure of chronic angle-closure glaucoma after phacoemulsification

朱研,杜立芳,邢怡桥
DOI: https://doi.org/10.3969/j.issn.1671-2420.2010.04.011
2010-01-01
Abstract:Objective To investigate the intraocular pressure (IOP)-lowering effect of Travoprost in patients with chronic angle-closure glaucoma (CACG) after phacoemulsification. Methods Once-daily treatment with Travoprost 0.004% was applied to 15 CACG patients after phacoemulsification. The diurnal variation of IOP was measured before treatment,and 1 week,4 and 8 weeks post-treatment respectively. The peak and fluctuation range of IOP in diurnal variation curve was identified. Results The mean peak IOP was (23.83±3.74) mm Hg (1 mm Hg=0.133 kPa) at baseline before treatment and(15.25±3.71)mm Hg 1 week after treatment(P<0.01),with the mean percentage of IOP reduction being 36%. The fluctuation range of the diurnal variation also decreased significantly after treatment (P<0.01). No serious or clinically significant adverse events were observed. Conclusions Travoprost 0.004% was well tole-rated which could significantly reduce IOP in CACG after phacoemulsification.
What problem does this paper attempt to address?